Skip to content

Position Nº 01PHARMA / MENAStatus: Settled

Roche Diabetes Care

Launched an AI-enabled CGM across four Gulf markets under MOHAP and SFDA pharma rules.

Realized returns

Kuwait, Qatar, KSA and UAE launched under MOHAP + SFDA
Aided brand awareness lift in target diabetes audience (Kantar)
HCP-safe inventory pre-cleared via ChannelFactory

The order

MENA pharma advertising sits inside a separate rulebook from e-commerce: UAE MOHAP and Saudi SFDA require pre-approval, prohibit prescription DTC claims, and treat HCP and patient audiences as legally distinct. Most regional agencies don't know these rules until campaigns get paused. Roche needed a four-market launch (Kuwait, Qatar, KSA, then UAE) where every asset, audience and placement was compliant from day one and brand metrics, not last-click ROAS, were the measurement layer.

How it was won

  1. 01

    Built a four-market media plan with budget weighted by population, GDP-per-capita and IDF-published diabetes prevalence data

  2. 02

    Pre-cleared every YouTube channel via a ChannelFactory contextual whitelist tuned for HCP-safe and patient-safe inventory at the placement level

  3. 03

    Locked compliance gates with Meta Business Portfolio and Google policy teams pre-flight, not post-rejection

  4. 04

    Designed a brand-lift measurement plan (Kantar and Meta Brand Lift) reading aided awareness, message recall and intent as the right pharma KPIs

Worked with

  • Meta
  • Google Ads
  • YouTube
  • ChannelFactory
  • Pharma Compliance (MOHAP/SFDA)
  • Brand Lift Study
  • Multi-market Launch